Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 45, 2019
Previous Article Next Article

Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

Author affiliations

Abstract

Based on the similar mechanism shared by diabetes mellitus (DM) and Alzheimer's disease (AD), we previously demonstrated that insulin-enhancing vanadyl complexes could preserve cognitive functions in an AD model of APP/PS1 mice after the emergence of β-amyloid (Aβ) plaques. Herein, we further studied the preventive effects of vanadyl complexes. Vanadyl acetylacetonate (VAC) was given to 3-month-old APP/PS1 mice, whose Aβ levels in the brain started to rise with unobservable deposits. Results showed that VAC could ameliorate Aβ pathogenesis in APP/PS1 mice but was less effective than that administrated at 5 months of age. Investigation on the molecular mechanism revealed that compared with vanadium treatment after Aβ plaque formation, earlier VAC administration showed increased clearance of Aβ deposition in the cerebral cortex, however, was much less effective in neuronal protection due to the failure to activate the Grp75 chaperone. These results suggest that neural cells under Aβ burden might exhibit different metabolic patterns and intracellular signal transduction before and after Aβ plaque formation, thus responding differently to vanadyl complexes at different intervention stages. Further studies clarifying the mechanism of the stage-dependent actions of vanadium would be helpful for the rational design of effective anti-AD vanadium agents and better understanding of AD pathogenesis.

Graphical abstract: Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

Back to tab navigation

Article information


Submitted
15 Feb 2019
Accepted
01 Jun 2019
First published
03 Jun 2019

New J. Chem., 2019,43, 17588-17594
Article type
Paper

Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

C. Tan, Y. Dong, J. Wang and X. Yang, New J. Chem., 2019, 43, 17588
DOI: 10.1039/C9NJ00820A

Social activity

Search articles by author

Spotlight

Advertisements